Vascular Closure Devices Market Report 2026

Vascular Closure Devices Market Overview

• Vascular Closure Devices market size has reached to $1.62 billion in 2025 • Expected to grow to $2.31 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Cardiovascular Disease Prevalence Fuels Growth In Vascular Closure Devices Market • Market Trend: Advancements In Vascular Closure Devices • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Vascular Closure Devices Market?

A vascular closure device is a medical device that seals the entry point in an artery after a catheterization procedure. These devices are designed to accelerate the natural healing process and minimize the risk of bleeding, hematoma formation, or other complications at the access site. The main types of vascular closure devices are passive approximators, active approximators, and external hemostatic devices. Passive approximators refer to devices or techniques that employ a plug, sealant, or gel at the arteriotomy site without physically closing the arteriotomy itself. The various access types are femoral access and radial access used in acute care facilities, hospitals, clinics, and others.

What Is The Vascular Closure Devices Market Growth Forecast?

The vascular closure devices market size is expected to see strong growth in the next few years. It will grow to $2.31 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to shift toward radial access approaches in cath labs, increasing utilization of external hemostatic and adjustable compression devices, expanding interventional cardiology capacity in emerging markets, rising investments in access site safety and complication reduction, growing preference for minimally invasive closure technologies. Major trends in the forecast period include increasing adoption of vascular closure devices to reduce post-catheterization complications, rising demand for closure systems that minimize bleeding and hematoma formation, growing procedural volumes in interventional cardiology and angiography requiring reliable access site sealing, expanding clinical shift toward faster patient ambulation and reduced hospital stay durations, increasing preference for closure devices that enhance workflow efficiency and patient safety.

Global Vascular Closure Devices Market Segmentation

1) By Type: Passive Approximators, Active Approximators, External Hemostatic Devices 2) By Access: Femoral Access, Radial Access 3) By End User: Acute Care Facilities, Hospitals, Clinics, Other End Users Subsegments: 1) By Passive Approximators: Suture-Based Devices, Fibrin Sealants 2) By Active Approximators: Mechanical Devices, Expanding Devices 3) By External Hemostatic Devices: Compression Bandages, Adjustable Hemostatic Devices

What Are The Drivers Of The Vascular Closure Devices Market?

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the vascular closure devices market. Cardiovascular disease (CVD) refers to conditions that affect the structures or function of the heart or blood vessels, affecting blood flow to the heart. Vascular closure devices (VCDs) are a substitute for conventional mechanical compression to close the femoral artery and offer rapid sealing of the femoral artery access site, potentially resulting in quicker attainment of hemostasis and a reduced risk of bleeding or hemorrhage following placement. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular diseases is expected to propel the growth of the vascular closure devices industry. The increasing prevalence of obesity is anticipated to drive the expansion of the vascular closure devices market going forward. Obesity refers to the medical condition characterized by an excess accumulation of body fat to the extent that has a negative impact on a person's health and creates imbalance between calories consumed and calories spent by a person. Vascular closure devices are used for overweight and obese patients to reduce the risk of bleeding complications and to address challenges in medical procedures with anatomical factors and potential complications related to excess adipose tissue in the body. For instance, in March 2023, according to the World Heart Foundation, a Switzerland-based non-government global cardiovascular community, globally around 2.3 billion adults and children are obese or overweight, and with the current obesity trend, it is estimated that the number of people living with obesity will reach 2.7 billion by 2025. Therefore, the increasing prevalence of obesity is driving the growth of the vascular closure devices industry.

Key Players In The Global Vascular Closure Devices Market

Major companies operating in the vascular closure devices market are Abbott Laboratories, Terumo Corporation, Teleflex Incorporated, Haemonetics Corporation, Vasorum Ltd, INVAMED Inc, Vivasure Medical Ltd, Merit Medical Systems Inc, Rex Medical, Transluminal Technologies LLC, Tricol Biomedical Inc, Essential Medical Inc, InSeal Medical Ltd, Meril Life Sciences Pvt Ltd, Forge Medical, Vascular Closure Systems Ltd, Aachen Resonance GmbH, LeMaitre Vascular, Acandis GmbH, MiCroPort Scientific Co Ltd.

Global Vascular Closure Devices Market Trends and Insights

Major companies operating in the vascular closure devices market are focused on developing technologies such as innovative collapsible disc technology to enhance patient outcomes, reduce recovery times, and improve the overall effectiveness and ease of vascular procedures. Innovative collapsible disc technology involves a design that allows a disc to be easily collapsed and expanded for efficient storage and portability. This technology enhances convenience and versatility in various applications, such as sporting goods, outdoor gear, or packaging solutions. For instance, in June 2024, Haemonetics Corporation, a US-based medical technology company, launched VASCADE MVP XL. VASCADE MVP XL is a mid-bore vascular closure device. The VASCADE MVP XL incorporates 58% more collagen and a larger disc compared to its predecessor, the VASCADE MVP system. This design aims to provide a more robust closure solution, facilitating quicker recovery and improved patient outcomes.

Regional Outlook

North America was the largest region in the vascular closure devices market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vascular Closure Devices Market?

The vascular closure devices market consists of sales of clip-based devices, suture-based devices, plug-based devices, and compression devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.